Paradigm Asset Management CO LLC Laboratory Corp Of America Holdings Transaction History

Paradigm Asset Management CO LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$209.01 - $232.56 $41,802 - $46,512	-200 Reduced 3.7%	5,201 $1.14 Million
Q4 2023 Feb 12, 2024	SELL	$197.69 - $227.29 $19,769 - $22,729	-100 Reduced 1.82%	5,401 $1.23 Million
Q3 2023 Oct 31, 2023	SELL	$201.05 - $221.7 $40,210 - $44,340	-200 Reduced 3.51%	5,501 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $868,913 - $989,453	4,100 Added 256.09%	5,701 $1.38 Million
Q4 2022 Feb 13, 2023	SELL	$203.72 - $248.97 $1.34 Million - $1.64 Million	-6,600 Reduced 80.48%	1,601 $376,000
Q3 2022 Nov 09, 2022	SELL	$204.81 - $262.19 $61,443 - $78,657	-300 Reduced 3.53%	8,201 $1.68 Billion
Q2 2022 Aug 08, 2022	BUY	$213.86 - $277.87 $256,632 - $333,444	1,200 Added 16.44%	8,501 $1.99 Million
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $136,071 - $157,419	501 Added 7.37%	7,301 $2.29 Million
Q3 2021 Nov 12, 2021	SELL	$274.82 - $308.34 $82,446 - $92,501	-300 Reduced 4.23%	6,800 $1.91 Million
Q1 2021 May 11, 2021	SELL	$204.88 - $255.03 $40,976 - $51,006	-200 Reduced 2.74%	7,100 $1.81 Million
Q4 2020 Feb 12, 2021	BUY	$186.91 - $214.42 $1.36 Million - $1.57 Million	7,300 New	7,300 $1.49 Million
Q2 2020 Aug 11, 2020	SELL	$113.31 - $182.44 $73,651 - $118,586	-650 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$163.48 - $173.61 $8,173 - $8,680	-50 Reduced 7.14%	650 $109,000
Q2 2019 Aug 08, 2019	SELL	$144.16 - $172.9 $57,664 - $69,160	-400 Reduced 36.36%	700 $0
Q1 2019 May 14, 2019	BUY	$123.7 - $156.3 $136,070 - $171,930	1,100 New	1,100 $0

1.95M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Paradigm Asset Management CO LLC with notifications on news.